Krynica Vitamin Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Piotr Czachorowski
Chief executive officer
zł619.0k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 9.6yrs |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | no data |
Recent management updates
Recent updates
Insufficient Growth At Krynica Vitamin S.A. (WSE:KVT) Hampers Share Price
Dec 19
Here's What To Make Of Krynica Vitamin's (WSE:KVT) Decelerating Rates Of Return
Aug 07Getting In Cheap On Krynica Vitamin S.A. (WSE:KVT) Is Unlikely
Mar 09Krynica Vitamin's (WSE:KVT) Conservative Accounting Might Explain Soft Earnings
Jan 06Krynica Vitamin (WSE:KVT) Is Experiencing Growth In Returns On Capital
Sep 02Krynica Vitamin (WSE:KVT) Is Looking To Continue Growing Its Returns On Capital
Oct 27These 4 Measures Indicate That Krynica Vitamin (WSE:KVT) Is Using Debt Extensively
Jul 07Krynica Vitamin (WSE:KVT) May Have Issues Allocating Its Capital
Dec 11Why Krynica Vitamin's (WSE:KVT) Shaky Earnings Are Just The Beginning Of Its Problems
Sep 01Is Krynica Vitamin (WSE:KVT) Using Too Much Debt?
May 20Why We Like The Returns At Krynica Vitamin (WSE:KVT)
Mar 10Krynica Vitamin S.A.'s (WSE:KVT) Stock Is Going Strong: Is the Market Following Fundamentals?
Feb 17
Krynica Vitamin (WSE:KVT) Has A Rock Solid Balance Sheet
Jan 27Krynica Vitamin (WSE:KVT) Has Rewarded Shareholders With An Exceptional 335% Total Return On Their Investment
Jan 06CEO
Piotr Czachorowski
9.6yrs
Tenure
zł619,000
Compensation
Mr. Piotr Czachorowski has been the President of the Management Board at Krynica Vitamin S.A. since May 14, 2015 and serves as its Member of Management Board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/18 12:24 |
| End of Day Share Price | 2024/12/18 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Krynica Vitamin S.A. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|